切换至 "中华医学电子期刊资源库"

中华脑科疾病与康复杂志(电子版) ›› 2022, Vol. 12 ›› Issue (01) : 58 -61. doi: 10.3877/cma.j.issn.2095-123X.2022.01.010

病例报告

钻孔引流联合尿激酶治疗华法林相关性硬膜下血肿一例报道并文献复习
杜小林1, 周焜1, 魏宜功1, 乔志立1, 王诚1,()   
  1. 1. 550084 贵阳,贵州医科大学附属金阳医院神经外科
  • 收稿日期:2021-12-09 出版日期:2022-02-15
  • 通信作者: 王诚
  • 基金资助:
    贵阳市高层次创新型青年卫生人才项目

Drilling drainage combined with urokinase in the treatment of warfarin related chronic subdural hematoma: a case report and literature review

Xiaolin Du1, Kun Zhou1, Yigong Wei1   

  • Received:2021-12-09 Published:2022-02-15
引用本文:

杜小林, 周焜, 魏宜功, 乔志立, 王诚. 钻孔引流联合尿激酶治疗华法林相关性硬膜下血肿一例报道并文献复习[J/OL]. 中华脑科疾病与康复杂志(电子版), 2022, 12(01): 58-61.

Xiaolin Du, Kun Zhou, Yigong Wei. Drilling drainage combined with urokinase in the treatment of warfarin related chronic subdural hematoma: a case report and literature review[J/OL]. Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition), 2022, 12(01): 58-61.

图1 患者治疗前后影像学检查A:术前CT示,双侧额颞顶枕部硬膜下混合血肿;B:术前MRI示,双侧额颞顶枕部见广泛短T1、稍长T2信号影;右侧基底节-放射冠、右岛叶多发软化灶;双侧额颞顶枕部广泛硬膜下血肿;C:术后48 h CT示,血肿残留,以高信号为主;D:术后96 h CT、尿激酶2 d后,尿激酶引流管内注入后血肿引流满意;E:术后3个月CT示,硬膜下血肿明显吸收,未见复发
[1]
Baechli H, Nordmann A, Bucher HC, et al. Demographics and prevalent risk factors of chronic subdural haematoma: results of a large single-center cohort study[J]. Neurosurg Rev, 2004, 27(4): 263-266.
[2]
Ducruet AF, Grobelny BT, Zacharia BE, et al. The surgical management of chronic subdural hematoma[J]. Neurosurg Rev, 2012, 35(2): 155-169; discussion 169.
[3]
Yadav YR, Parihar V, Namdev H, et al. Chronic subdural hematoma[J]. Asian J Neurosurg, 2016, 11(4): 330-342.
[4]
Hernández-Díaz ZM, Llíbre-Guerra JC, Arteche-Prior M, et al. Spontaneous subdural hematoma and behavioral changes due to a dural arteriovenous fistula. A Case Report and Literature Review[J]. Behav Sci (Basel), 2019, 9(6): 63.
[5]
Li G, Zhang Y, Zhao J, et al. Isolated subdural hematoma secondary to dural arteriovenous fistula: a case report and literature review[J]. BMC Neurol, 2019, 19(1): 43.
[6]
Ban SP, Hwang G, Byoun HS, et al. Middle meningeal artery embolization for chronic subdural hematoma[J]. Radiology, 2018, 286(3): 992-999.
[7]
中华医学会神经外科学分会,中国神经外科重症管理协作组.抗栓药物治疗中颅内出血患者神经外科围手术期管理中国专家共识(2018版)[J].中华医学杂志, 2018, 98(21): 1640-1645.
[8]
Taussky P, Fandino J, Landolt H. Number of burr holes as independent predictor of postoperative recurrence in chronic subdural haematoma[J]. Br J Neurosurg, 2008, 22(2): 279-282.
[9]
Han HJ, Park CW, Kim EY, et al. One vs. two burr hole craniostomy in surgical treatment of chronic subdural hematoma[J]. J Korean Neurosurg Soc, 2009, 46(2): 87-92.
[10]
Kansal R, Nadkarni T, Goel A. Single versus double burr hole drainage of chronic subdural hematomas. A study of 267 cases[J]. J Clin Neurosci, 2010, 17(4): 428-429.
[11]
Wan Y, Xie D, Xue Z, et al. Single versus double burr hole craniostomy in surgical treatment of chronic subdural hematoma: a meta-analysis[J]. World Neurosurg, 2019, 131: e149-e154.
[12]
Oh HJ, Lee KS, Shim JJ, et al. Postoperative course and recurrence of chronic subdural hematoma[J]. J Korean Neurosurg Soc, 2010, 48(6): 518-523.
[13]
Bartley A, Jakola AS, Tisell M. The influence of irrigation fluid temperature on recurrence in the evacuation of chronic subdural hematoma[J]. Acta Neurochir (Wien), 2020, 162(3): 485-488.
[14]
Kuwabara M, Sadatomo T, Yuki K, et al. The effect of irrigation solutions on recurrence of chronic subdural hematoma: a consecutive cohort study of 234 patients[J]. Neurol Med Chir (Tokyo), 2017, 57(5): 210-216.
[15]
Gernsback J, Kolcun JP, Jagid J. To drain or two drains: recurrences in chronic subdural hematomas[J]. World Neurosurg, 2016, 95: 447-450.
[16]
Javadi A, Amirjamshidi A, Aran S, et al. A randomized controlled trial comparing the outcome of burr-hole irrigation with and without drainage in the treatment of chronic subdural hematoma: a preliminary report[J]. World Neurosurg, 2011, 75(5-6): 731-736; discussion 620-623.
[17]
Alcalá-Cerra G, Young AM, Moscote-Salazar LR, et al. Efficacy and safety of subdural drains after burr-hole evacuation of chronic subdural hematomas: systematic review and meta-analysis of randomized controlled trials[J]. World Neurosurg, 2014, 82(6): 1148-1157.
[18]
Yeo CG, Jeon WY, Kim SH, et al. The effectiveness of subdural drains using urokinase after burr hole evacuation of subacute subdural hematoma in elderly patients: a prelimilary report[J]. Korean J Neurotrauma, 2016, 12(2): 101-106.
[19]
Cho SW, Choi SW, Lim J, et al. Burr hole drainage with urokinase irrigation for the treatment of acute subdural hematoma: a case report[J]. Korean J Neurotrauma, 2018, 14(2): 142-145.
[20]
Lam J, Lee DJ, Oladunjoye A. Subdural catheter injection of tissue plasminogen activator for residual hematoma post drainage of acute-on-chronic subdural hematoma: novel case report of 2 patients[J]. World Neurosurg, 2020, 133: 266-270.
[21]
Li Y, Yang R, Li Z, et al. Urokinase vs tissue-type plasminogen activator for thrombolytic evacuation of spontaneous intracerebral hemorrhage in basal ganglia[J]. Front Neurol, 2017, 8: 371.
[22]
Iorio-Morin C, Blanchard J, Richer M, et al. Tranexamic acid in chronic subdural hematomas (TRACS): study protocol for a randomized controlled trial[J]. Trials, 2016, 17(1): 235.
[23]
Schaumann A, Klene W, Rosenstengel C, et al. COXIBRAIN: results of the prospective, randomised, phase II/III study for the selective COX-2 inhibition in chronic subdural haematoma patients[J]. Acta Neurochir (Wien), 2016, 158(11): 2039-2044.
[24]
Jiang R, Zhao S, Wang R, et al. Safety and efficacy of atorvastatin for chronic subdural hematoma in Chinese patients: a randomized clinical trial[J]. JAMA Neurol, 2018, 75(11): 1338-1346.
[25]
Prud'homme M, Mathieu F, Marcotte N, et al. A pilot placebo controlled randomized trial of dexamethasone for chronic subdural hematoma[J]. Can J Neurol Sci, 2016, 43(2): 284-290.
[26]
Yao Z, Hu X, Ma L, et al. Dexamethasone for chronic subdural haematoma: a systematic review and meta-analysis[J]. Acta Neurochir (Wien), 2017, 159(11): 2037-2044.
[27]
Xu XP, Liu C, Liu J, et al. Local application of corticosteroids combined with surgery for the treatment of chronic subdural hematoma[J]. Turk Neurosurg, 2015, 25(2): 252-255.
[28]
Tanweer O, Frisoli FA, Bravate C, et al. Tranexamic acid for treatment of residual subdural hematoma after bedside twist-drill evacuation[J]. World Neurosurg, 2016, 91: 29-33.
[29]
林晓宁,田新华,孙瑾,等.慢性硬膜下血肿术后复发的危险因素分析[J].中华神经外科杂志, 2019, 35(3): 302-304.
[30]
Kim SU, Lee DH, Kim YI, et al. Predictive factors for recurrence after burr-hole craniostomy of chronic subdural hematoma[J]. J Korean Neurosurg Soc, 2017, 60(6): 701-709.
[31]
Motiei-Langroudi R, Stippler M, Shi S, et al. Factors predicting reoperation of chronic subdural hematoma following primary surgical evacuation[J]. J Neurosurg, 2018, 129(5): 1143-1150.
[32]
Fornebo I, Sjåvik K, Alibeck M, et al. Role of antithrombotic therapy in the risk of hematoma recurrence and thromboembolism after chronic subdural hematoma evacuation: a population-based consecutive cohort study[J]. Acta Neurochir (Wien), 2017, 159(11): 2045-2052.
[33]
Gaist D, García Rodríguez LA, Hellfritzsch M, et al. Association of antithrombotic drug use with subdural hematoma risk[J]. JAMA, 2017, 317(8): 836-846.
[1] 刘子洋, 崔俭俭, 赵茵. 产科弥散性血管内凝血及其评分系统的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 511-518.
[2] 姚金含, 王伟娜, 张玉泉. 妊娠相关深静脉血栓形成患者的预后研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 367-373.
[3] 陈杨, 李茜, 杨中华. 慢性阻塞性肺疾病急性加重期合并VTE抗凝治疗的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(02): 316-319.
[4] 丁镇涛, 邢博涵, 曲洋, 王泊江, 张培训. 老年肱骨近端骨折的围手术期治疗策略[J/OL]. 中华肩肘外科电子杂志, 2024, 12(04): 292-294.
[5] 唐全兴, 周畅. 维持性血液透析患者血清suPAR对动静脉内瘘狭窄发生的诊断价值[J/OL]. 中华肾病研究电子杂志, 2024, 13(02): 74-78.
[6] 王永楠, 汤畅通, 殷杰, 谭溢涛. 微创钻孔引流术与神经内镜血肿清除术治疗临界量基底节脑出血的效果对比分析[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 286-292.
[7] 曹文钰, 郭鹏, 李锦平. 微创手术及非手术方式治疗慢性硬膜下血肿的研究进展[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 304-309.
[8] 林庆喜, 曾钦霖, 谢琛璠, 魏梁锋. 封闭式钻孔引流联合阿托伐他汀治疗慢性硬膜下血肿的疗效观察[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(02): 91-96.
[9] 李晴, 丁玉珍, 樊尚荣. 妊娠合并机械心脏瓣膜患者血栓形成抗凝治疗的研究[J/OL]. 中华产科急救电子杂志, 2024, 13(01): 41-48.
[10] 胡浩, 曹葳, 何益兴, 安天志. 导管接触性溶栓治疗卵巢静脉血栓二例并文献复习[J/OL]. 中华介入放射学电子杂志, 2024, 12(01): 90-92.
[11] 彭思远, 贺王成, 梁国华, 罗冰, 田英, 李晓丹, 肖晴, 毛曼, 区晓雯, 耿文艳. 枸橼酸钠抗凝比例及校正采血量分别对正常人和贫血患者血栓弹力图试验结果的影响[J/OL]. 中华临床实验室管理电子杂志, 2024, 12(01): 22-26.
[12] 王海珍, 马永明, 姚可盈. 尿激酶治疗结核性包裹性胸腔积液疗效的系统评价与荟萃分析[J/OL]. 中华胸部外科电子杂志, 2024, 11(01): 53-61.
[13] 王学建, 汪志峰, 钱明, 姜雷, 宋校伟, 胡伟梁. 比较神经内镜与钻孔引流对慢性硬膜下血肿疗效的Meta分析[J/OL]. 中华卫生应急电子杂志, 2024, 10(02): 65-69.
[14] 李芳, 戴西望, 王凯, 郭廷昊, 涂江龙. 非瓣膜性心房颤动相关性卒中的治疗研究进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 393-397.
[15] 周雅萍, 洪月慧, 苏宁, 刘暴, 朱铁楠, 倪俊. 脑淀粉样血管病合并易栓状态的临床治疗决策[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 338-344.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?